MBS303

· Beijing Mabworks Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBS303, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL [Phase 1, Phase 2]

See pricing